MedTrace Logo

Iodine-125 Seed Implantation Therapy for Locally Advanced Pancreatic Cancer

NCT03882866 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2020-02-06

No results posted yet for this study

Summary

This study evaluates the application of 3D-printed template for iodine-125 seed implantation therapy in patients with locally advanced pancreatic cancer. Half of participants will receive 3D-printed coplanar template, while the other half will receive 3D-printed non-coplanar template.

Conditions

Interventions

PROCEDURE

3D-printed non-coplanar template

3D-printed non-coplanar template is used in the intervention group. Iodine-125 seed implantation therapy is assisted using 3D-printed non-coplanar template as a guide in patients with locally advanced pancreatic cancer. 3D-printed non-coplanar template is designed and printed according to a preoperative CT scan and treatment planning system.

PROCEDURE

3D-printed coplanar template

3D-printed coplanar template is used in the intervention group. Iodine-125 seed implantation therapy is assisted using 3D-printed coplanar template as a guide in patients with locally advanced pancreatic cancer. 3D-printed coplanar template is designed and printed according to a preoperative CT scan and treatment planning system.

Sponsors & Collaborators

  • Hebei General Hospital

    collaborator OTHER

  • Zhongda Hospital

    collaborator OTHER

  • Anhui Provincial Hospital

    collaborator OTHER_GOV

  • The Second Hospital of Shandong University

    collaborator OTHER

  • Sun Yat-sen University

    collaborator OTHER

  • Chinese PLA General Hospital

    collaborator OTHER

  • Huadong Hospital

    collaborator OTHER

  • Tengzhou Central People's Hospital

    collaborator OTHER_GOV

  • Ruijin Hospital

    lead OTHER

Principal Investigators

  • Zhongmin Wang, MD · Ruijin Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-03-28
Primary Completion
2021-06-30
Completion
2021-09-30

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03882866 on ClinicalTrials.gov